Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Iradimed (IRMD) FCF Margin (2016 - 2025)

Iradimed (IRMD) has disclosed FCF Margin for 13 consecutive years, with 5.77% as the latest value for Q4 2025.

  • Quarterly FCF Margin fell 3527.0% to 5.77% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 20.5% through Dec 2025, down 1338.0% year-over-year, with the annual reading at 20.5% for FY2025, 1338.0% down from the prior year.
  • FCF Margin for Q4 2025 was 5.77% at Iradimed, down from 60.3% in the prior quarter.
  • The five-year high for FCF Margin was 60.3% in Q3 2025, with the low at 31.39% in Q3 2023.
  • Average FCF Margin over 5 years is 23.32%, with a median of 26.32% recorded in 2021.
  • The sharpest move saw FCF Margin crashed -5933bps in 2023, then surged 8582bps in 2024.
  • Over 5 years, FCF Margin stood at 27.6% in 2021, then plummeted by -32bps to 18.71% in 2022, then skyrocketed by 214bps to 58.76% in 2023, then plummeted by -50bps to 29.5% in 2024, then tumbled by -120bps to 5.77% in 2025.
  • According to Business Quant data, FCF Margin over the past three periods came in at 5.77%, 60.3%, and 25.04% for Q4 2025, Q3 2025, and Q2 2025 respectively.